Changes in bone mineral density in the proximal femur after hip resurfacing and uncemented total hip replacement: A prospective randomised controlled study
- PMID: 21037344
- DOI: 10.1302/0301-620X.92B11.24785
Changes in bone mineral density in the proximal femur after hip resurfacing and uncemented total hip replacement: A prospective randomised controlled study
Abstract
We undertook a randomised prospective follow-up study of changes in peri-prosthetic bone mineral density (BMD) after hip resurfacing and compared them with the results after total hip replacement. A total of 59 patients were allocated to receive a hip resurfacing (n = 29) or an uncemented distally fixed total hip replacement (n = 30). The BMD was prospectively determined in four separate regions of interest of the femoral neck and in the calcar region corresponding to Gruen zone 7 for the hip resurfacing group and compared only to the calcar region in the total hip replacement group. Standardised measurements were performed pre-operatively and after three, six and 12 months. The groups were well matched in terms of gender distribution and mean age. The mean BMD in the calcar region increased after one year to 105.2% of baseline levels in the resurfaced group compared with a significant decrease to 82.1% in the total hip replacement group (p < 0.001) by 12 months. For the resurfaced group, there was a decrease in bone density in all four regions of the femoral neck at three months which did not reach statistical significance and was followed by recovery to baseline levels after 12 months. Hip resurfacing did indeed preserve BMD in the inferior femoral neck. In contrast, a decrease in the mean BMD in Gruen zone 7 followed uncemented distally fixed total hip replacement. Long term follow-up studies are necessary to see whether this benefit in preservation of BMD will be clinically relevant at future revision surgery.
Similar articles
-
Changes in bone mineral density of the acetabulum, femoral neck and femoral shaft, after hip resurfacing and total hip replacement: two-year results from a randomised study.J Bone Joint Surg Br. 2012 Aug;94(8):1036-44. doi: 10.1302/0301-620X.94B8.28222. J Bone Joint Surg Br. 2012. PMID: 22844043 Clinical Trial.
-
Changes in the bone mineral density in the acetabulum and proximal femur after cementless total hip replacement: alumina-on-alumina versus alumina-on-polyethylene articulation.J Bone Joint Surg Br. 2007 Feb;89(2):174-9. doi: 10.1302/0301-620X.89B2.18634. J Bone Joint Surg Br. 2007. PMID: 17322430 Clinical Trial.
-
Pattern of periprosthetic bone remodeling around stable uncemented tapered hip stems: a prospective 84-month follow-up study and a median 156-month cross-sectional study with DXA.Calcif Tissue Int. 2003 Aug;73(2):115-21. doi: 10.1007/s00223-002-2036-z. Calcif Tissue Int. 2003. PMID: 14565592
-
New polymer materials in total hip arthroplasty. Evaluation with radiostereometry, bone densitometry, radiography and clinical parameters.Acta Orthop Suppl. 2005 Feb;76(315):3-82. Acta Orthop Suppl. 2005. PMID: 15790289 Review.
-
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis.J Orthop Surg Res. 2018 Jun 7;13(1):144. doi: 10.1186/s13018-018-0794-1. J Orthop Surg Res. 2018. PMID: 29880021 Free PMC article. Review.
Cited by
-
Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.BMC Musculoskelet Disord. 2017 May 22;18(1):209. doi: 10.1186/s12891-017-1577-2. BMC Musculoskelet Disord. 2017. PMID: 28532408 Free PMC article. Clinical Trial.
-
The effect of simvastatin on periprosthetic bone mineral density in the hypercholesterolaemic patients after total hip arthroplasty.Int Orthop. 2018 Jan;42(1):59-64. doi: 10.1007/s00264-017-3551-x. Epub 2017 Jul 5. Int Orthop. 2018. PMID: 28681228
-
Resurfacing hip arthroplasty better preserves a normal gait pattern at increasing walking speeds compared to total hip arthroplasty.Acta Orthop. 2019 Jun;90(3):231-236. doi: 10.1080/17453674.2019.1594096. Epub 2019 Apr 1. Acta Orthop. 2019. PMID: 30931667 Free PMC article. Clinical Trial.
-
Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty.Eur J Orthop Surg Traumatol. 2018 Dec;28(8):1601-1607. doi: 10.1007/s00590-018-2223-x. Epub 2018 May 17. Eur J Orthop Surg Traumatol. 2018. PMID: 29774416
-
Metal ion levels and functional results after either resurfacing hip arthroplasty or conventional metal-on-metal hip arthroplasty.Acta Orthop. 2011 Oct;82(5):559-66. doi: 10.3109/17453674.2011.625533. Acta Orthop. 2011. PMID: 22103280 Free PMC article. Clinical Trial.